Prostate Cancer
The COMPASs Study: Community Preferences for Prostate cAncer Screening. Protocol for a quantitative preference study - Abstract
February 2, 2012
Frequency and determinants of disagreement and error in Gleason scores: A population-based study of prostate cancer - Abstract
February 2, 2012
Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies - Abstract
February 2, 2012
Diagnostic performance of malignant prostatic cells detection in blood for early detection of prostate cancer: Comparison to prostatic biopsy - Abstract
February 2, 2012
Dynamic contrast-enhanced MR imaging findings of bone metastasis in patients with prostate cancer - Abstract
February 2, 2012
Factors implicated in radiation therapy failure and radiosensitization of prostate cancer - Abstract
February 2, 2012
Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model - Abstract
February 2, 2012
Prognostic determinants in prostate cancer - Abstract
February 2, 2012
Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer - Abstract
February 2, 2012
α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth - Abstract
February 2, 2012
Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness - Abstract
February 2, 2012
Meta-analysis demonstrates no association between p53 codon 72 polymorphism and prostate cancer risk - Abstract
February 2, 2012
The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy - Abstract
February 1, 2012
Optimal baseline prostate-specific antigen level to distinguish risk of prostate cancer in healthy men between 40 and 69 years of age - Abstract
February 1, 2012